OncoTAb, Inc. was founded by Mayo Clinic alumna Dr. Pinku Mukherjee, focused on addressing unmet cancer diagnostic and therapeutic needs. The company first product: Agkura⢠Personal Score is a simple, non-invasive blood test aiding breast cancer detection in women with dense breast tissue where the condition impedes early detection. the product measures the biomarker tumor-associated MUC1 (tMUC1) and shows a trend of increasing value from benign disease through breast cancer stages 1 to 4. Women can monitor their personal score in conjunction with annual mammograms. A score above the normal range or an increase greater than normal variation will trigger a recommendation for diagnostic imaging (ultrasound or MRI), resulting in earlier stage diagnosis of breast cancer. The companyâs pipeline products include imaging and therapeutic applications of its novel platform technology targeted to other unmet nee
